Other drugs targeting mTOR pathway such as NVP-BEZ235, a mTOR inhibitor, also inhibited proliferation and normalized kidney morphology in ADPKD (Liu et al., 2018). This evidence concerns the gene MTOR and autosomal dominant polycystic kidney disease.